How many employees does Insmed Incorporated have?

Insmed Incorporated reported 1,664 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 19, 2026. That is up 30.9% from a year earlier.

What is Insmed Incorporated's revenue per employee?

Insmed Incorporated brought in $606M of revenue in fiscal Dec 2025, which is $364K per employee. That ranks 27 of 39 companies we track in Biotechnology, where the median is $602K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Insmed Incorporated employees and revenue per employee

INSM · Biotechnology · $24.1B market cap

Insmed Incorporated had 1,664 employees at the end of fiscal Dec 2025, up 30.9% from a year earlier. Revenue for the year was $606M, up 66.7% from a year earlier, or $364K per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

1,664

+30.9% YoY

Revenue

$606M

+66.7% YoY

Revenue / employee

$364K

Peer median $602K

Rank in industry

27 of 39

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2018

Hover a year for the numbers.

INSM employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	1,664	$606M	$364K	+30.9%	+66.7%
Dec 2024	1,271	$364M	$286K	+39.4%	+19.2%
Dec 2023	912	$305M	$335K	+23.9%	+24.4%
Dec 2022	736	$245M	$333K	+20.1%	+30.2%
Dec 2021	613	$188M	$307K	+17.7%	+14.6%
Dec 2020	521	$164M	$316K	+19.8%	+20.5%
Dec 2019	435	$136M	$314K	+16.6%	+1287.6%
Dec 2018	373	$9.8M	$26K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Insmed Incorporated against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
BCRX BioCryst Pharmaceuticals, Inc.	435	$875M	$2.01M	Leaner
TGTX TG Therapeutics, Inc.	399	$616M	$1.54M	Efficient growth
ARWR Arrowhead Pharmaceuticals, Inc.	711	$829M	$1.17M	Efficient growth
ADMA ADMA Biologics, Inc.	647	$510M	$789K	Leaner
AXSM Axsome Therapeutics, Inc.	925	$638M	$690K	Efficient growth
IONS Ionis Pharmaceuticals, Inc.	1,402	$944M	$673K	Efficient growth
BBIO BridgeBio Pharma, Inc.	834	$502M	$602K	Efficient growth
TXG 10x Genomics, Inc.	1,178	$643M	$546K	Leaner
INSM Insmed Incorporated	1,664	$606M	$364K	Efficient growth

Every Healthcare company

Questions about Insmed Incorporated

How many employees does Insmed Incorporated have?: Insmed Incorporated reported 1,664 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 19, 2026. That is up 30.9% from a year earlier.
What is Insmed Incorporated's revenue per employee?: Insmed Incorporated brought in $606M of revenue in fiscal Dec 2025, which is $364K per employee. That ranks 27 of 39 companies we track in Biotechnology, where the median is $602K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare INSM with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Insmed Incorporated's annual reports (Form 10-K), latest filed February 19, 2026. This is data, not a recommendation to buy or sell INSM.